CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2017—MDxHealth was awarded a U.S. General Services Administration supply contract to use ConfirmMDx for Prostate Cancer within the Department of Veterans Affairs.
The five-year contract, effective Feb. 1, provides coverage of ConfirmMDx testing at the Medicare rate for veterans within the VA health system. According to the VA, prostate cancer is the most frequently diagnosed cancer among veterans, with roughly 12,000 new cases annually, and it is estimated that more than 200,000 prostate biopsies are performed within the VA health care system each year.
MDxHealth, 866-259-5644